NEWS

PRESS RELEASE

Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stim...

Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform

PRESS RELEASE

Philips announces WE-TRUST multicenter clinical trial to assess impact o...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial to assess the impact of a ‘Direct to Angio Suite’ workflow on stroke patient outcomes.

PRESS RELEASE

Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile

Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery

PRESS RELEASE

Sim&Cure Announces U.S. FDA 510(k) Clearance for Sim&Size software

Montpellier – Sim&Cure is honored and proud to announce last September 17, Sim&Size® obtained U.S.Food and Drug Administration (FDA) 510(k) clearance.

PRESS RELEASE

Phenox Announces Exclusive Distribution Agreement with Wallaby Medical I...

Phenox is pleased to announce that it has signed an exclusive distribution agreement with Wallaby Medical Inc. for commercialization of The Avenir™ Detachable Coil System in the U.S. and EU markets.

PRESS RELEASE

Wallaby Medical Inc. announces CE Mark and FDA Clearance of the Avenir™...

Wallaby Medical announces CE Mark approval and FDA 510(k) clearance of its differentiated embolic coil system, the Avenir Coil System. The intended use for the Avenir Coil System is for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir Coil System is also intended for arterial and venous embolization in the peripheral vasculature.

PRESS RELEASE

1st Pass Success with NeVa™ "M1S" (4.0 x 22 mm) after failure of 2 diffe...

Watch this clinical case report from a 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset.It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Additional risk factors included: Coronary Heart Failure, Hypertension, Diabetes, Atrial fibrillation.On admission CT ASPECTS was 10.Imaging confirmed distal left MCA occlusion.

PRESS RELEASE

Medtronic Partners with Viz.ai to Accelerate Adoption of New Artificial...

DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI) in stroke care, have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronize stroke care and decrease time to treatment, potentially improving outcomes for patients.

PRESS RELEASE

Vesalio obtains additional CE approval for new products, NeVa clinical d...

Nashville, TN, May 22, 2019 Vesalio announces it has obtained its second CE Approval spanning multiple new NeVa™ product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies while also introducing first to market features such as a distal filter.  A controlled launch of the new technology will begin in June in Europe with expected full commercial release in Q4 of this year.

PRESS RELEASE

Vesalio Secures $5 Million Investment Capital Funding

Nashville, TN, May 14, 2019 Vesalio announces it has recently raised $5 million in funding.  The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions.